Order Article Reprints

Watanabe A, Yamashita K, Fujita M, Arimoto A, Nishi M, Takamura S, Saito M, Yamada K, Agawa K, Mukoyama T, et al. Vaccine Based on Dendritic Cells Electroporated with an Exogenous Ovalbumin Protein and Pulsed with Invariant Natural Killer T Cell Ligands Effectively Induces Antigen-Specific Antitumor Immunity. Cancers. 2022; 14(1):171. https://doi.org/10.3390/cancers14010171

Watanabe, Akihiro, Kimihiro Yamashita, Mitsugu Fujita, Akira Arimoto, Masayasu Nishi, Shiki Takamura, Masafumi Saito, Kota Yamada, Kyosuke Agawa, Tomosuke Mukoyama, and et al. 2022. "Vaccine Based on Dendritic Cells Electroporated with an Exogenous Ovalbumin Protein and Pulsed with Invariant Natural Killer T Cell Ligands Effectively Induces Antigen-Specific Antitumor Immunity" Cancers 14, no. 1: 171. https://doi.org/10.3390/cancers14010171

Watanabe, A., Yamashita, K., Fujita, M., Arimoto, A., Nishi, M., Takamura, S., Saito, M., Yamada, K., Agawa, K., Mukoyama, T., Ando, M., Kanaji, S., Matsuda, T., Oshikiri, T., & Kakeji, Y. (2022). Vaccine Based on Dendritic Cells Electroporated with an Exogenous Ovalbumin Protein and Pulsed with Invariant Natural Killer T Cell Ligands Effectively Induces Antigen-Specific Antitumor Immunity. Cancers, 14(1), 171. https://doi.org/10.3390/cancers14010171